Barkby Group PLC (The) Verso Biosense signs collaboration agreement
April 08 2021 - 2:00AM
RNS Non-Regulatory
TIDMBARK
Barkby Group PLC (The)
08 April 2021
8 April 2021
The Barkby Group PLC
("Barkby", the "Group" or the "Company")
Verso Biosense signs agreement with London Women's Clinic
The Barbky Group PLC is pleased to announce that Verso Biosense,
an innovator in UK femtech focused on improving women's health, is
delighted to announce the signing of its second product
collaboration agreement with one of the UK's leading fertility
clinics, London Women's Clinic.
London Women's Clinic will collaborate with Verso, using its
uterine monitoring device to refine the technology and biosensing
platform to meet the needs of its fertility patients. Verso's
platform captures critical in-vivo, biosensing data for
optimisation and personalisation of IVF treatment, providing
actionable insights for clinicians and patients.
The London Women's Clinic provides world-class fertility care to
women and couples across England and Wales. Since it was
established in 1985 in Harley Street, it has pioneered many of the
routine techniques used to treat fertility today. London Women's
Clinic has regional centres in the South East, North East, and West
of England, and Wales.
Joseph Cefai, Head of Product Development at Verso Biosense,
commented:
"We are delighted to announce our partnership with the London
Women's Clinic, a true leader in providing world-class fertility
treatment to women and couples. It is testament to the potential of
our ground-breaking platform that this is the second partnership we
have announced in the space of a few of weeks, following our
agreement with Homerton University Hospital in March. We are moving
at pace to provide our monitoring platform to meet the needs of
patients and we are delighted by the progress that we are
making."
Enquiries:
The Barkby Group PLC
Charles Dickson, Executive Chairman
Douglas Benzie, Chief Financial Officer
+44 (0) 20 7220
finnCap Ltd (Nomad and Broker) 0500
Carl Holmes/Simon Hicks (corporate finance)
Tim Redfern/Richard Chambers (ECM)
+44 (0) 20 3757
Camarco (Financial PR) 4994
Jennifer Renwick/Jake Thomas
Notes to editors
The Barkby Group PLC is a diversified group of high growth, high
quality businesses run by an entrepreneurial and experienced
management team. The existing wholly owned businesses within Barkby
include; Commercial Property Development, Barkby Hospitality
(comprising Barkby Pubs and Workshop Coffee) and Centurian
Automotive Ltd.
In addition to these businesses, Barkby Life Sciences has
invested in Verso Biosense, a digital health company aiming to
transform Women's Health with precision medicine, and its
subsidiary Cambridge Sleep Sciences Ltd has launched, SleepHub(TM),
a device which improves and facilitates natural sleep.
Barkby's strategy is to accelerate and maximise opportunities
within its existing businesses as well as continue to source and
invest in cash generative, growth businesses with the ability to
disrupt.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAIRMPTMTTMBAB
(END) Dow Jones Newswires
April 08, 2021 02:00 ET (06:00 GMT)
Barkby (LSE:BARK)
Historical Stock Chart
From Apr 2024 to May 2024
Barkby (LSE:BARK)
Historical Stock Chart
From May 2023 to May 2024